OVID Ovid Therapeutics Inc.
Healthcare$2.47+1.23%ClosedMarket Cap: $325.8M
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$5.50
Target (Median)
$5.50
Target Range
$4.00 - $7.00
Upside from current price: 122.7%
Rating Distribution
0 Strong Buy10 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-04-15 | Wedbush | maintain | Outperform | Outperform |
| 2026-04-09 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-03-26 | BTIG | maintain | Buy | Buy |
| 2025-12-22 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-05-27 | HC Wainwright & Co. | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-0.53 | $237.5K | 7 |
| Sun Dec 31 | $-0.66 | $230.0K | 6 |
| Mon Dec 31 | $-0.60 | $10.7M | 4 |
| Tue Dec 31 | $-0.13 | $76.9M | 2 |